31607504|t|Prevalence and Improvement of Caine-Positive Wernicke-Korsakoff Syndrome in Psychiatric Inpatient Admissions.
31607504|a|BACKGROUND: Wernicke-Korsakoff Syndrome (WKS) resulting from thiamine deficiency is classically defined as including encephalopathy, ataxia, and ophthalmoplegia. Only 16% of autopsy-confirmed patients with WKS exhibit all three signs. Caine-positive WKS criteria include two or more of the following: nutritional deficiency, delirium or mild memory impairment, cerebellar dysfunction/ataxia, and oculomotor abnormalities. OBJECTIVE: We describe Caine-positive WKS prevalence among psychiatric inpatients and compare pretreatment-versus-posttreatment neurocognitive improvement to an unaffected group. METHODS: This 6-month quality-improvement evaluation included two-stage screening for Caine-positive WKS, administering high-dose intravenous thiamine (day 1: 1200 mg; days 2-4: 200 mg) with reexamination on day 5. We used descriptive statistics and fitted random effects models to examine rate-of-change differences in pre-/posttreatment Montreal Cognitive Assessment (MoCA), delayed 5-item recall, and gait/coordination scores between treated Caine-positive patients with WKS and untreated Caine-negative patients. RESULTS: Of 262 patients, 32 (12%) had Caine-positive WKS; 17 (53%) used alcohol currently. Treated Caine-positive WKS (n = 26) versus Caine-negative comparison (n = 34) before and after treatment observed a mean change (standard deviation) in the MoCA score of 3.6 (2.5) versus 1.8 (2.5) (P < 0.01); 5-item recall: 1.8 (1.4) versus 0.5 (1.4) (P < 0.001); gait/coordination scores: -0.6 (1.2) versus -0.1 (0.6) (P < 0.001). Oculomotor abnormalities were infrequent (n = 4 in Caine-positive WKS, n = 2 in Caine-negative comparison groups). CONCLUSIONS: Caine-positive WKS prevalence among psychiatric inpatients was 12%; only half used alcohol. Patients treated with high-dose thiamine demonstrated clinically significant neurocognitive improvement.
31607504	30	35	Caine	Chemical	-
31607504	45	72	Wernicke-Korsakoff Syndrome	Disease	MESH:D020915
31607504	122	149	Wernicke-Korsakoff Syndrome	Disease	MESH:D020915
31607504	151	154	WKS	Disease	MESH:D020915
31607504	171	190	thiamine deficiency	Disease	MESH:D013832
31607504	227	241	encephalopathy	Disease	MESH:D001927
31607504	243	249	ataxia	Disease	MESH:D001259
31607504	255	270	ophthalmoplegia	Disease	MESH:D009886
31607504	302	310	patients	Species	9606
31607504	316	319	WKS	Disease	MESH:D020915
31607504	345	350	Caine	Chemical	-
31607504	360	363	WKS	Disease	MESH:D020915
31607504	411	433	nutritional deficiency	Disease	MESH:D044342
31607504	435	443	delirium	Disease	MESH:D003693
31607504	452	469	memory impairment	Disease	MESH:D008569
31607504	471	493	cerebellar dysfunction	Disease	MESH:D002526
31607504	494	500	ataxia	Disease	MESH:D001259
31607504	506	530	oculomotor abnormalities	Disease	MESH:D015840
31607504	555	560	Caine	Chemical	-
31607504	570	573	WKS	Disease	MESH:D020915
31607504	591	613	psychiatric inpatients	Disease	MESH:D001523
31607504	797	802	Caine	Chemical	-
31607504	812	815	WKS	Disease	MESH:D020915
31607504	853	861	thiamine	Chemical	MESH:D013831
31607504	1156	1161	Caine	Chemical	-
31607504	1171	1179	patients	Species	9606
31607504	1185	1188	WKS	Disease	MESH:D020915
31607504	1203	1208	Caine	Chemical	-
31607504	1218	1226	patients	Species	9606
31607504	1244	1252	patients	Species	9606
31607504	1267	1272	Caine	Chemical	-
31607504	1282	1285	WKS	Disease	MESH:D020915
31607504	1301	1308	alcohol	Chemical	MESH:D000438
31607504	1328	1333	Caine	Chemical	-
31607504	1343	1346	WKS	Disease	MESH:D020915
31607504	1363	1368	Caine	Chemical	-
31607504	1652	1676	Oculomotor abnormalities	Disease	MESH:D015840
31607504	1703	1708	Caine	Chemical	-
31607504	1718	1721	WKS	Disease	MESH:D020915
31607504	1732	1737	Caine	Chemical	-
31607504	1780	1785	Caine	Chemical	-
31607504	1795	1798	WKS	Disease	MESH:D020915
31607504	1816	1838	psychiatric inpatients	Disease	MESH:D001523
31607504	1863	1870	alcohol	Chemical	MESH:D000438
31607504	1872	1880	Patients	Species	9606
31607504	1904	1912	thiamine	Chemical	MESH:D013831
31607504	Positive_Correlation	MESH:D000438	MESH:D020915
31607504	Negative_Correlation	MESH:D013831	MESH:D020915

